Surgical management of sternoclavicular joint infections  by Burkhart, Harold M. et al.
Surgical management of sternoclavicular joint infections
Harold M. Burkhart, MD
Claude Deschamps, MD
Mark S. Allen, MD
Francis C. Nichols III, MD
Daniel L. Miller, MD
Peter C. Pairolero, MD
Objective: Sternoclavicular joint infections are rare, and their management is
controversial. We reviewed our experience with the surgical management of this
condition.
Methods: From August 1988 to August 2001, 26 patients (16 men and 10 women)
were treated surgically for infected sternoclavicular joints. The median age was 56
years (range, 20-77 years). Patients who had a recent previous median sternotomy
were excluded.
Results: All patients were symptomatic. Pain was present in 21 patients, swelling in
14 patients, fever in 11 patients, and erythema in 9 patients. Associated conditions
included recent or ongoing infections in other areas in 12 patients (pneumonia in 4
patients, multiple joint infections in 2 patients, and other in 6 patients) and an
indwelling central venous catheter in 1 patient. Five patients had a history of trauma
in the region of the joint. Four patients had prior joint incision and drainage.
Unilateral sternoclavicular joint resection was done in 18 patients, bilateral resection
in 2 patients, and incision and drainage with debridement in 6 patients. Wound
culture results were positive in 24 patients, and the most common organism isolated
was Staphylococcus aureus (n  17). Eleven patients had transposition of the
ipsilateral pectoralis major muscle to obliterate residual space and to reconstruct the
chest wall. Two (7.7%) patients had complications, and 1 died (operative mortality,
3.8%). Follow-up was complete in all 25 operative survivors and ranged from 2
months to 10 years (median, 25 months). Twenty-one patients are alive without
symptoms, infection, or limitations in range of motion. Four patients have died as
a result of causes unrelated to their joint infections.
Conclusions: Symptomatic sternoclavicular joint infections often require surgical
intervention. Surgical resection combined with muscle transposition provides effec-
tive long-term outcome.
Sternoclavicular joint (SCJ) infections are rare. Their cause and pre-sentation is not well characterized. Similarly, the management of SCJinfections is controversial.1 Management strategies have ranged fromconservative antibiotic therapy to surgical resection of the SCJ with orwithout muscle transposition. The purpose of this review is to analyzeour experience with the surgical management of SCJ infections.
Patients and Methods
Between August 1, 1988, and August 1, 2001, all patients who underwent surgical manage-
ment of SCJ infection at the Mayo Clinic in Rochester, Minn, were reviewed. Patients who
had SCJ infection as a result of an infected median sternotomy were excluded. The records
of these patients were analyzed for age, sex, preoperative symptoms, roentgenographic
findings, operative procedures, microbiology data, and clinical outcome. Operative mortality
included those patients who died within the first 30 days after the operation and those who
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died later but during the same hospitalization. Follow-up was
obtained through outpatient clinic visits, correspondence with local
physicians, and telephone interviews.
There were 16 men and 10 women in the study. The median age
was 56 years and ranged from 20 to 77 years. Twelve patients had
recent or ongoing infections in other locations that included pneu-
monia in 4 patients, sepsis with multiple joint infections in 2
patients, and spontaneous bacterial peritonitis, abdominal abscess,
infected knee prosthesis, cutaneous ulcer infection, hand cellulitis,
and bacteremia in 1 patient each. Five patients had a history of
trauma in the region of the joint, and one had an ipsilateral
indwelling subclavian venous catheter. Other comorbidities in-
cluded diabetes mellitus in 8 patients, connective tissue disorders
in 3 patients, steroid use in 3 patients, radiation therapy after a
modified radical mastectomy in 2 patients, and acute myelocytic
leukemia in 1 patient. Presenting signs and symptoms were present
in all 26 patients and included pain in 21 (81.7%) patients, swell-
ing in 14 (53.8%) patients, fever in 11 (42.3) patients, erythema in
9 (34.6%) patients, and purulent drainage in 3 (11.5%) patients.
The SCJ infection was on the right in 16 (61.5%) patients, on the
left in 8 (30.7%) patients, and bilateral in 2 (7.7%) patients.
Parenteral antibiotics were administered preoperatively in 12
(46.1%) patients and ranged from 2 to 48 days, with a median of
14 days before surgical intervention.
A chest roentgenograph was performed in all patients and
demonstrated a mass in the region of the SCJ in 4 patients and
bone destruction in 2 patients. The remaining 20 (81%) chest
roentgenographs were interpreted as normal. Computed tomogra-
phy (CT) of the chest was performed in 22 patients and demon-
strated SCJ swelling in 10 patients, bone destruction in 9 patients,
an abscess in 9 patients, and a mass in 2 patients. A radionuclide
bone scan was performed in 8 patients, and the results were
abnormal in 7 patients.
Wound cultures were obtained in all 26 patients, and results
were positive in 24 (92.3%) patients. Staphylococcus aureus was
isolated in 17 patients (65.4%), Streptococcus species in 4 (15.4%)
patients, Escherichia coli in 2 (7.7%) patients, and multiple or-
ganisms in 1 (3.8%) patient. Blood cultures were obtained in 19
(73.0%) patients and demonstrated the same organism as found in
the wound in 11 patients.
SCJ resection was performed in 20 patients (unilateral in 18
patients and bilateral in 2 patients), and incision and drainage with
debridement was performed in 6 patients. In performing SCJ
resections, our preference has been to make a supraclavicular
incision that extends from the medial third of the involved clavicle
toward the suprasternal notch and then down the midline to the
sternomanubrial junction. The attachment of the sternocleidomas-
toid muscle is separated from the clavicle, and the pectoralis major
muscle is dissected from the manubrium and anterior chest wall for
several centimeters toward the midaxillary line. The clavicle is
then divided just lateral to the SCJ, followed by midline division
of the manubrium to just below the first costochondral arch. The
entire first costochondral arch is now removed, and the SCJ is
resected en bloc, with care taken to avoid damage to the underlying
subclavian vein and internal thoracic vessels.
In the patients who had SCJ resection, primary wound closure
was done in 2 patients, and delayed closure was done in 12
patients. In the remaining 6 patients, the wound was closed by
means of secondary intention. Four of the 20 patients who had SCJ
resection had prior incision and drainage. In the 6 patients who had
SCJ incision and drainage with debridement, the wounds in 2
patients were closed primarily, 2 patients had delayed closure, and
2 patients healed by secondary intention. Eleven (55%) of the 20
patients undergoing SCJ resection underwent transposition of the
ipsilateral pectoralis major muscle to obliterate residual space and
reconstruct the chest wall. Twenty (77.0%) patients received post-
operative antibiotics for a median of 42 days (range, 14-56 days).
Results
Median hospitalization was 14 days (range, 3-110 days).
There was one operative death (mortality, 3.8%). This pa-
tient had multiple joint infections and underwent bilateral
SCJ resections. She died 3 months after resection but during
the same hospitalization as a result of sepsis and multisys-
tem organ failure. At the time of death, the area of joint
resection had healed and had no evidence of drainage. Two
(7.7%) patients had postoperative complications. One pa-
tient with SCJ resection who had delayed closure without
muscle transposition had recurrent infection 9 days after
closure and required reopening. This wound eventually
healed by secondary intention. The other complication oc-
curred in a patient who had unstable angina and required
coronary artery bypass grafting and mitral valve repair in
the early postoperative period.
Follow-up was complete in all 25 operative survivors
and ranged from 2 months to 10 years (median, 26 months).
Twenty-one patients are currently alive without symptoms,
infection, or limitations in range of motion. Four patients
have died as a result of causes unrelated to their joint
infections. Causes of death included acute myelocytic leu-
kemia, cerebral vascular accident, hepatic failure, and acci-
dental hypothermia.
Discussion
The SCJ is synovial lined and composed of the inferior,
medial clavicular head, the superior lateral notch of the
manubrium, and the cartilage of the first rib. Clinical infec-
tions of this joint are rare but, when present, result in
abscess formation in 20% of patients.2 Because the joint
capsule is unable to distend, infection quickly spreads be-
yond the joint, leading to fistula formation, cutaneous ab-
scesses, or, rarely, mediastinitis.3-4 Given the joint’s close
relationship to the mediastinum, pleural cavity, and brachio-
cephalic structures, thoracic surgeons will often be con-
sulted and should be familiar with the surgical management
of an infected SCJ.
SCJ infection has been reported in association with cen-
tral venous catheters, intravenous drug abuse, multijoint
infections, local trauma, and immunosuppression from dia-
betes mellitus, chronic steroid use, hemodialysis, and HIV
infection.1,5-9 SCJ infections have also been reported to
occur spontaneously in otherwise healthy patients.10 Carlos
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and colleagues5 reported on a surgical series of 8 patients,
with the suspected source of infection being a subclavian
vein catheter in 4 patients and a subclavian vein pacemaker
in 1 patient. In the series reported by Song and associates,1
the most common risk factor for SCJ infection was immu-
nosuppression. Similarly, a variety of underlying causes
was found in our patients.
Patients with suspected SCJ infection should be evalu-
ated with both chest roentgenography and chest CT. Al-
though chest roentgenography in our experience has a low
likelihood of diagnosing SCJ infection, it might be useful in
evaluating other types of thoracic problems. Although our
preference has been to image the SCJ with CT (Figure 1),
magnetic resonance scans can be of equal value. If the
imaging studies are equivocal, however, a radionuclide
bone scan might be helpful. If no evidence of abscess or
bone destruction is found and an SCJ infection is suspected,
parenteral antibiotics should be instituted. When doubt per-
sists as to the diagnosis, incision and drainage can be
performed to obtain tissue sample for histologic examina-
tion and culture. However, when either abscess or bone
destruction exists, we advocate resection of the SCJ.
Song and associates1 reported that 5 of their 6 patients
undergoing SCJ resection had previous drainage and de-
bridement. More than two thirds of our patients required
SCJ resection, and 15% had undergone previous incision
and drainage. Our results and those from other reported
series1,5 support aggressive surgical management (Table 1).
We have previously reported the utility of muscle transpo-
sition in controlling local infection in other anatomic loca-
TABLE 1. SCJ infections: Reported series
Author
Patients
(n)
Contributing factors
(n)
Treatment
(n)
Muscle
flap (n) Outcome
Carlos and associates5 8 Central venous catheter (5) Resection (4);
I & D (4)
4 Good
0
Song and associates1 7 Immunosupression (4) Resection (6);
I & D (1)
6 Good
0
Current study 26 Immunosupression (4);
other infections (12)
Resection (20);
I & D (6)
11 Good
0
I & D, Incision and drainage.
Figure 1. CT at the level of the left SCJ demonstrating bone destruction with air (arrows) in the surrounding soft
tissues.
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tions.11 For lesions of the anterior chest wall, transposition
of the pectoralis major muscle on the basis of the thora-
coacromial neurovascular leash without division of the hu-
meral attachments is ideal. This provides for excellent local
infection control and obliteration of residual space, as well
as maintaining pectoralis major function.
In conclusion, SCJ infections often require surgical in-
tervention. Joint resection combined with muscle transpo-
sition is effective and results in both a healed chest wall
without evidence of infection and preservation of shoulder
function in most patients.
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Discussion
Dr Malcolm M. DeCamp, Jr (Cleveland, Ohio). SCJ infections
are uncommon, but with an increasing number of immunocom-
promised hosts in our practice, as well as patients with indwelling
intravascular prostheses, it is perhaps an entity that is on the rise.
Dr Burkhart and his colleagues from the Mayo Clinic are to be
congratulated for their complete report of this unusual but chal-
lenging problem. They build on their published experience with
the use of muscle flaps to help remedy a variety of thoracic defects
and infections. This current work is arguably the largest surgical
series of SCJs managed to date. As leaders in the field of thoracic
muscle flaps, the authors can use their experience to help guide us.
I have several questions. Is there any way to define the denom-
inator in terms of SCJ infection? I suspect that is difficult, and
therefore, if not, can the authors provide criteria to help the
surgeons decide when to incise and drain and when to resect?
Were there clinical factors that predicted success with either in-
tervention?
Eleven of your 20 resected joint spaces were reconstructed with
ipsilateral pectoral muscle. Were there clinical factors favoring
immediate muscle flap closure versus delayed closure versus those
that were allowed to heal by secondary intention?
How is postoperative shoulder function assessed? Did the de-
gree of clavicular resection affect shoulder function or chronic
pain?
Finally, can you comment on the unusual problem of bilateral
SCJ resections? Unfortunately, one of your patients died. Never-
theless, how were these wounds managed? Was the entire manu-
brium resected? What was the long-term functional result in your
one survivor?
Dr Burkhart. Thank you for your comments, Dr DeCamp.
You point out a couple of the limitations in this report, and the first
one is whether we can define the common denominator. No matter
what we tried to evaluate, looking at all the patients in the medical
wards and surgical wards who had been admitted to the hospital
over that time period, there were only 2 or 3 that came up as
actually having SCJ infections that were not treated surgically, and
we do not know if there are more. However, in predicting when to
do incision and drainage and when to do a resection, I think we
have done resections on the last several patients, and I think that is
our preferred route in almost all patients. The patient undergoing
incision and drainage would typically be one who could not
undergo an operation for medical reasons, sepsis, or hemodynamic
instability. Possibly, we might be unsure about the diagnosis; the
patient might have erythema on the joint and we would want to see
whether an infection was in fact present. However, if any of the
patients specifically have an abscess or bone destruction or ongo-
ing sepsis with that as a point of infection, have a recurrence of the
infection after incision and drainage, or, in addition, have persis-
tence of infection despite adequate medical therapy for 2 weeks or
so, we try to perform a resection. As far as when to use flap
closure, both immediate and delayed, only about 55% of the
resections had muscle flaps. I will first start by saying that we do
get plastic surgery involved in the management of the wound with
all of these resections, at least at the time of the operation. When
deciding on whether to do a flap, the biggest question is whether
the patient has adequate soft tissue to cover the operative site. If
patients have a lot of soft tissue in the upper chest and, after the
resection is done, there is just a small defect and they have quite
a bit of subcutaneous tissue and muscle, then the wound is closed
by secondary intention. However, if they are thin, there is a large
defect, or their brachiocephalic structures are exposed, we tend to
do a muscle flap.
As you pointed out, primary closure was used in 2 patients. In
most of them, because of the nature of the infection, the wound is
packed for a few days before being closed primarily. I think it is
a rarity that we close such wounds primarily. Of those 2 patients,
1 of them had an abscess on CT scan and 1 of them had bone
destruction on a chest radiograph; neither of them had any comor-
bidity factors or diabetes, which would have made us think that
they would have a difficult time healing. Therefore, in those 2 patients
the wound was actually closed immediately and they did well.
Postoperative functional status was the other limitation of this
study. We do not have any objective data. This was all purely
subjective, either seeing the patients in the clinic and asking them
about their shoulder as compared with before the operation and
also talking with them on the telephone. Of note, and I do not think
this is necessarily the same for everybody, I did speak to an elderly
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gentleman in his 70s who had a resection a few years ago and who
said that his golf game was a lot better now. I am not recommend-
ing that, but it did help him.
With regard to bilateral resections go, we treated 2 patients in
this manner and, as you mentioned, 1 of them died. This patient’s
whole manubrium ended up being necrotic, and it was removed.
She was sick the whole time, and there was no way to assess her
function. She was bedridden and also obese. In the other patient we
tried to preserve the manubrium. Rather than taking half the
manubrium midline, we took about a third on each side to leave a
little bit of the manubrium island. But again, that was 1 patient of
25 who survived. Therefore, that is what we tried to do in that
situation, and that person did have a single muscle flap that
covered both defects.
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